Search details
1.
Focal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis.
Mol Psychiatry
; 2023 Mar 29.
Article
in English
| MEDLINE | ID: mdl-36991131
2.
Circadian rhythms in bipolar disorder patient-derived neurons predict lithium response: preliminary studies.
Mol Psychiatry
; 26(7): 3383-3394, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33674753
3.
Correction of depression-associated circadian rhythm abnormalities is associated with lithium response in bipolar disorder.
Bipolar Disord
; 24(5): 521-529, 2022 08.
Article
in English
| MEDLINE | ID: mdl-34825444
4.
Clinical predictors of non-response to lithium treatment in the Pharmacogenomics of Bipolar Disorder (PGBD) study.
Bipolar Disord
; 23(8): 821-831, 2021 12.
Article
in English
| MEDLINE | ID: mdl-33797828
5.
The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
BMC Psychiatry
; 16: 129, 2016 May 05.
Article
in English
| MEDLINE | ID: mdl-27150464
6.
Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes.
PLoS Genet
; 7(6): e1002134, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21738484
7.
Neural progenitor cells derived from lithium responsive and non-responsive bipolar disorder patients exhibit distinct sensitivity to cell death following methamphetamine.
Neuropharmacology
; 226: 109410, 2023 03 15.
Article
in English
| MEDLINE | ID: mdl-36608815
8.
Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder.
Eur Neuropsychopharmacol
; 74: 1-14, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37126998
9.
Evidence for association of bipolar disorder to haplotypes in the 22q12.3 region near the genes stargazin, IFT27 and parvalbumin.
Am J Med Genet B Neuropsychiatr Genet
; 159B(8): 941-50, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-23038240
10.
Associations between inflammatory marker profiles and neurocognitive functioning in people with schizophrenia and non-psychiatric comparison subjects.
J Psychiatr Res
; 149: 106-113, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35259663
11.
Promise and pitfalls of animal models of schizophrenia.
Curr Psychiatry Rep
; 12(4): 327-34, 2010 Aug.
Article
in English
| MEDLINE | ID: mdl-20544314
12.
Oxytocin improves probabilistic reversal learning but not effortful motivation in Brown Norway rats.
Neuropharmacology
; 150: 15-26, 2019 05 15.
Article
in English
| MEDLINE | ID: mdl-30844406
13.
Efficient region-based test strategy uncovers genetic risk factors for functional outcome in bipolar disorder.
Eur Neuropsychopharmacol
; 29(1): 156-170, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30503783
14.
The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.
Psychopharmacology (Berl)
; 200(2): 197-203, 2008 Oct.
Article
in English
| MEDLINE | ID: mdl-18568338
15.
The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.
Pharmacol Biochem Behav
; 90(4): 748-52, 2008 Oct.
Article
in English
| MEDLINE | ID: mdl-18577396
16.
A description of the ABCD organizational structure and communication framework.
Dev Cogn Neurosci
; 32: 8-15, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29706313
17.
The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats.
Behav Brain Res
; 181(2): 278-86, 2007 Aug 06.
Article
in English
| MEDLINE | ID: mdl-17559953
18.
Upregulation of striatal dopamine-2 receptors in Brattleboro rats with prepulse inhibition deficits.
Biol Psychiatry
; 60(11): 1278-81, 2006 Dec 01.
Article
in English
| MEDLINE | ID: mdl-16814260
19.
Differential regulation of immediate-early gene expression in the prefrontal cortex of rats with a high vs low behavioral response to methamphetamine.
Neuropsychopharmacology
; 31(11): 2359-67, 2006 Nov.
Article
in English
| MEDLINE | ID: mdl-16855532
20.
Potential of Oxytocin in the Treatment of Schizophrenia.
CNS Drugs
; 30(3): 193-208, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26895254